Tzyvia Rye

1.4k total citations
33 papers, 885 citations indexed

About

Tzyvia Rye is a scholar working on Reproductive Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Tzyvia Rye has authored 33 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Reproductive Medicine, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Tzyvia Rye's work include Ovarian cancer diagnosis and treatment (28 papers), Endometrial and Cervical Cancer Treatments (9 papers) and PARP inhibition in cancer therapy (6 papers). Tzyvia Rye is often cited by papers focused on Ovarian cancer diagnosis and treatment (28 papers), Endometrial and Cervical Cancer Treatments (9 papers) and PARP inhibition in cancer therapy (6 papers). Tzyvia Rye collaborates with scholars based in United Kingdom, United States and Canada. Tzyvia Rye's co-authors include Charlie Gourley, Alistair Williams, Melanie Mackean, Moira Stewart, Hani Gabra, Robert L. Hollis, Michael Churchman, C. Simon Herrington, Awatif Al‐Nafussi and Fiona Nussey and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Tzyvia Rye

30 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tzyvia Rye United Kingdom 17 565 286 285 271 162 33 885
Evelyn Despierre Belgium 13 373 0.7× 186 0.7× 156 0.5× 420 1.5× 298 1.8× 17 914
Qin Xu China 20 520 0.9× 550 1.9× 177 0.6× 326 1.2× 102 0.6× 57 1.1k
Kati Kämpjärvi Finland 12 581 1.0× 692 2.4× 97 0.3× 228 0.8× 98 0.6× 20 1.0k
Jennelle C. Hodge United States 19 178 0.3× 251 0.9× 119 0.4× 411 1.5× 191 1.2× 39 957
Chiara Della Pepa Italy 15 168 0.3× 109 0.4× 250 0.9× 199 0.7× 158 1.0× 22 640
Tomomi Sakamoto Japan 11 173 0.3× 122 0.4× 238 0.8× 337 1.2× 103 0.6× 22 615
Shuangdi Li China 16 180 0.3× 102 0.4× 168 0.6× 396 1.5× 336 2.1× 37 722
Bruce R. Krawisz United States 11 237 0.4× 311 1.1× 86 0.3× 164 0.6× 59 0.4× 19 663
Michelle Van Sinderen Australia 17 179 0.3× 265 0.9× 90 0.3× 231 0.9× 143 0.9× 26 756
Nicole Sänger Germany 14 159 0.3× 49 0.2× 263 0.9× 212 0.8× 139 0.9× 56 717

Countries citing papers authored by Tzyvia Rye

Since Specialization
Citations

This map shows the geographic impact of Tzyvia Rye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tzyvia Rye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tzyvia Rye more than expected).

Fields of papers citing papers by Tzyvia Rye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tzyvia Rye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tzyvia Rye. The network helps show where Tzyvia Rye may publish in the future.

Co-authorship network of co-authors of Tzyvia Rye

This figure shows the co-authorship network connecting the top 25 collaborators of Tzyvia Rye. A scholar is included among the top collaborators of Tzyvia Rye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tzyvia Rye. Tzyvia Rye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iida, Yasushi, Michael Churchman, Robert L. Hollis, et al.. (2025). Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma. Gynecologic Oncology. 198. 66–74.
2.
Thomson, John P., Robert L. Hollis, Michael Churchman, et al.. (2023). Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome. Gynecologic Oncology. 174. 157–166. 8 indexed citations
3.
Hollis, Robert L., John P. Thomson, Michael Churchman, et al.. (2023). Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma. Scientific Reports. 13(1). 7681–7681. 8 indexed citations
4.
Hollis, Robert L., Ian Croy, Michael Churchman, et al.. (2022). Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma. British Journal of Cancer. 127(6). 1034–1042. 25 indexed citations
5.
Hollis, Robert L., Bárbara Stanley, John P. Thomson, et al.. (2021). Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification. npj Precision Oncology. 5(1). 47–47. 16 indexed citations
6.
Hollis, Robert L., Samantha L. Hopkins, Clare Bartos, et al.. (2021). Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma. Cancers. 13(22). 5839–5839. 10 indexed citations
7.
Hollis, Robert L., John P. Thomson, Bárbara Stanley, et al.. (2020). Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome. Nature Communications. 11(1). 4995–4995. 83 indexed citations
8.
Irodi, Aparna, Tzyvia Rye, Karl E. Herbert, et al.. (2020). Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data. BJOG An International Journal of Obstetrics & Gynaecology. 127(11). 1409–1420. 34 indexed citations
9.
Hollis, Robert L., Juliet Carmichael, Alison Meynert, et al.. (2019). Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse. American Journal of Obstetrics and Gynecology. 221(3). 245.e1–245.e15. 20 indexed citations
10.
Hollis, Robert L., Bárbara Stanley, Yasushi Iida, et al.. (2019). Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma. Gynecologic Oncology. 155(2). 318–323. 22 indexed citations
11.
Hollis, Robert L., Alison Meynert, Michael Churchman, et al.. (2019). Abstract 749: Multi-layer molecular characterization of high grade serous ovarian carcinomas. 749–749. 1 indexed citations
12.
Stanley, Bárbara, Robert L. Hollis, Tzyvia Rye, et al.. (2018). Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors. Gynecologic Oncology. 152(2). 278–285. 22 indexed citations
13.
Xintaropoulou, Chrysi, Carol Ward, Arran Turnbull, et al.. (2018). Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment. BMC Cancer. 18(1). 636–636. 79 indexed citations
14.
Hollis, Robert L., Alison Meynert, Michael Churchman, et al.. (2018). Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations. BMC Cancer. 18(1). 16–16. 16 indexed citations
15.
Rafii, Saeed, Charlie Gourley, Joo Ern Ang, et al.. (2015). What clinical factors influence advanced BRCA1/2 mutant ovarian cancer patient (BMOC pt) outcomes to poly(ADP-ribose) polymerase inhibitor (PARPi) treatment?. Journal of Clinical Oncology. 33(15_suppl). 5546–5546. 1 indexed citations
16.
Tan, David S.P., Tzyvia Rye, Patricia Shaw, et al.. (2014). Analysis of outcomes in patients (pts) with recurrent ovarian clear cell carcinoma (ROCCC): Time to rethink our approach to treatment.. Journal of Clinical Oncology. 32(15_suppl). 5548–5548. 8 indexed citations
17.
Faluyi, Olusola Olusesan, Charlie Gourley, John F. Smyth, et al.. (2010). Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancer.. PubMed. 20(9). 1511–7. 5 indexed citations
18.
Gourley, Charlie, Caroline O. Michie, Patricia Roxburgh, et al.. (2010). Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype. Journal of Clinical Oncology. 28(15). 2505–2511. 74 indexed citations
19.
Storey, D., Robert Rush, Moira Stewart, et al.. (2008). Endometrioid epithelial ovarian cancer. Cancer. 112(10). 2211–2220. 61 indexed citations
20.
Brown, Ewan, Moira Stewart, Tzyvia Rye, et al.. (2004). Carcinosarcoma of the ovary. Cancer. 100(10). 2148–2153. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evelyn Despierre Breakdown of academic impact, for papers by Qin Xu Breakdown of academic impact, for papers by Kati Kämpjärvi Breakdown of academic impact, for papers by Jennelle C. Hodge Breakdown of academic impact, for papers by Chiara Della Pepa Breakdown of academic impact, for papers by Tomomi Sakamoto Breakdown of academic impact, for papers by Shuangdi Li Breakdown of academic impact, for papers by Bruce R. Krawisz Breakdown of academic impact, for papers by Michelle Van Sinderen Breakdown of academic impact, for papers by Nicole Sänger
Rankless by CCL
2026